← Open Payments lookup

AMMAR TRABOULSI: Open Payments

NPI 1225125610 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$660 in 31 payments from 10 companies in 2025. Trend: 2023 $513 · 2024 $420 · 2025 $660

Food & beverage: $660
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.16$217
Janssen Pharmaceuticals, Inc1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$99
Otsuka America Pharmaceutical, Inc.3$58
Alkermes, Inc.2$55
Neurocrine BioSciences, Inc.1$27
ABBVIE INC.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$20
Lundbeck LLC1$20
E.R. Squibb & Sons, L.L.C.1$18

Products named: Qelbree, SPRAVATO, CAPLYTA, REXULTI, ARISTADA, INGREZZA, VRAYLAR, TRINTELLIX.

Industry payments across CT — which companies pay providers there.